It has been shown to be effective for weight loss and improving cardiometabolic risk factors when compared to a placebo.1 It is known to most commonly cause gastrointestinal side effects1
The 68-week study showed participants on CagriSema lost about 23% of their body weight, compared with 12% for those taking cagrilintide by itself, 16% for those on semaglutide, and 2.3% for people on a placebo
If oral semaglutide is being considered, Rybelsus Semaglutide explains the tablet option in more detail
[PMC free article] [PubMed] [Google Scholar] 186.Adler AI, Stratton IM, Neil HA, et al
This difference may influence a patients preference or compliance with their treatment regimen
Gently pinch the skin between your thumb and fingers before inserting the needle